EP3412672 - Bibliographic data

FORME CRISTALLINE DE 2-BUTOXY-7-(4-(PYRROLIDIN-1-YLMETHYL) BENZYL)-5H-PYRROLO[3,2-D]PYRIMIDIN-4-AMINE EN TANT QU' AGONISTE DE TLR7, SON PROCÉDÉ DE PRÉPARATION ET SON UTILISATION

Last update 07/06/2025
Legal status Brevet déchu
Origin Euro-PCT
(73) Holder

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

No. 369 Yuzhou South Road Haizhou District
Lianyungang, Jiangsu 222062
Chine
(72) Inventors

Zhaozhong DING

288 Futezhong Road Pudong New Area
Shanghai 200131
Chine

Fei SUN

288 Futezhong Road Pudong New Area
Shanghai 200131
Chine

Yinghu HU

288 Futezhong Road Pudong New Area
Shanghai 200131
Chine

Yilong ZHOU

288 Futezhong Road Pudong New Area
Shanghai 200131
Chine

Zheng WANG

288 Futezhong Road Pudong New Area
Shanghai 200131
Chine

Rui ZHAO

No.369 Yuzhou South Rd. Haizhou District
Lianyungang Jiangsu 222062
Chine

Ling YANG

No.369 Yuzhou South Rd. Haizhou District
Lianyungang Jiangsu 222062
Chine
(74) Agent

Mail recipient

Mewburn Ellis LLP

Aurora Building Counterslip
Bristol BS1 6BX
Royaume-Uni
(21) Request number EP17747004.4
(22) Request date 04/02/2017
(11) Publication number EP3412672
Publication date 15/07/2020
(54) Title of the invention FORME CRISTALLINE DE 2-BUTOXY-7-(4-(PYRROLIDIN-1-YLMETHYL) BENZYL)-5H-PYRROLO[3,2-D]PYRIMIDIN-4-AMINE EN TANT QU' AGONISTE DE TLR7, SON PROCÉDÉ DE PRÉPARATION ET SON UTILISATION
(51) International classification C07D 487/04, A61K 31/519, A61P 31/12
International classification (before reform) None
Claimed priority

(31) Number: 201610082029
(32) Date: 05/02/2016
(33) Country: CN

Initial application None
Divisional application None
Expected annuity Annuity: 5 - Amount: 90 € - Due date 01/03/2021
Surtax: 5 - Amount: 18 € - Due date 02/09/2021
Last annuity None
Publication None
History

Publication de la délivrance du brevet européen - Legal date 15/07/2020

Entrée en période de grâce du brevet d'invention - Legal date 02/03/2021

Déchéance du brevet d'invention après période de grâce - Legal date 01/03/2021